```html

Zoonotic Tuberculosis (Mycobacterium bovis) – A Patient‑Friendly Guide

Overview

Zoonotic tuberculosis is a form of tuberculosis (TB) caused by the bacterium Mycobacterium bovis. Unlike the more common human TB strain (Mycobacterium tuberculosis), M. bovis primarily infects animals—especially cattle, deer, and wildlife—but can be transmitted to people who come into close contact with infected animals or consume contaminated animal products.

• Who it affects: Farmers, veterinarians, abattoir (slaughterhouse) workers, hunters, and anyone who drinks unpasteurized milk or handles raw meat from infected animals.
• Global prevalence: According to the World Health Organization (WHO), zoonotic TB accounts for 1–5 % of all human TB cases worldwide, with higher rates in low‑ and middle‑income countries where pasteurization and animal‑health controls are less consistent. In the United States, the CDC reports <≈150 human cases per year, most linked to animal exposure or raw dairy consumption.<sup>[1]</sup>
• Geographic hotspots: Sub‑Saharan Africa, parts of South America, Central Asia, and some Mediterranean countries.

Symptoms

Symptoms of zoonotic TB are virtually identical to those of pulmonary TB caused by M. tuberculosis. The disease can affect the lungs (most common) or spread to other organs (extrapulmonary). Onset is usually insidious, developing weeks to months after infection.

Pulmonary (Lung) Symptoms

• Chronic cough: lasts >2–3 weeks; may produce blood‑streaked sputum.
• Chest pain: often pleuritic (sharp, worsens with deep breathing).
• Shortness of breath: especially on exertion.
• Fatigue and weakness – a general feeling of being unwell.
• Fever & night sweats: low‑grade fevers that break out at night.
• Weight loss: unintentional loss of >5 % body weight.

Extrapulmonary Symptoms

• Lymphadenitis: swollen, painless lymph nodes—often in the neck (scrofula).
• Spinal (Pott) disease: back pain, spinal deformity, neurologic deficits.
• Genitourinary TB: painful urination, blood in urine, infertility.
• Meningitis: severe headaches, neck stiffness, altered mental status (rare but life‑threatening).
• Joint or bone infection: localized pain, swelling, reduced movement.

Causes and Risk Factors

How the bacterium spreads

M. bovis is transmitted to humans primarily through:

1. Ingestion of contaminated dairy products – especially raw or unpasteurized milk, cheese, or cream.
2. Aerosol inhalation – breathing air contaminated with droplets from coughing, sneezing, or during slaughter of infected animals.
3. Direct contact with lesions – skin cuts or abrasions that come into contact with infected animal tissue or bodily fluids.

Who is at higher risk?

• Occupational exposure: cattle farmers, veterinarians, meat‑processing workers, wildlife handlers.
• Consumers of raw dairy or undercooked meat from endemic regions.
• People living in close proximity to wildlife reservoirs (e.g., deer, badgers) where bovine TB is uncontrolled.
• Immunocompromised individuals (HIV infection, diabetes, chronic kidney disease, TNF‑α inhibitor therapy).
• Young children: extra‑pulmonary disease is more common.

Diagnosis

Because the clinical picture mirrors regular TB, a high index of suspicion is needed when a patient has TB‑compatible symptoms *and* a history of animal exposure or raw‑milk consumption.

Diagnostic steps

• Medical history & physical exam – focus on exposure, symptoms, and risk factors.
• Chest radiograph (X‑ray) – reveals typical TB infiltrates, cavities, or hilar lymphadenopathy.
• Sputum microscopy – acid‑fast bacilli (AFB) stain (Ziehl‑Neelsen or fluorochrome). Positive AFB does not differentiate species.
• Culture – sputum, tissue, or body fluid cultured on Lowenstein‑Jensen medium; takes 4–6 weeks.
• Polymerase chain reaction (PCR) / GeneXpert – rapid detection of Mycobacterium DNA, can identify M. bovis in many labs.
• Species identification – biochemical tests (e.g., niacin negativity, pyrazinamide resistance) and molecular sequencing confirm M. bovis. Notably, M. bovis is *intrinsically resistant* to pyrazinamide (PZA), a key first‑line TB drug.
• Interferon‑gamma release assays (IGRAs) or tuberculin skin test (TST) – indicate TB infection but cannot differentiate species.
• Extrapulmonary sampling – fine‑needle aspiration of lymph nodes, CSF analysis for meningitis, or bone biopsy when disease is outside the lungs.

All diagnostic procedures should be performed in certified laboratories following biosafety guidelines.

Treatment Options

Standard TB regimens must be modified because M. bovis is resistant to pyrazinamide (PZA). The World Health Organization (WHO) and the CDC recommend a 6–9‑month regimen using four first‑line drugs, excluding PZA.

Medication regimen

• Isoniazid (INH) – 5 mg/kg (max 300 mg) daily.
• Rifampin (RIF) – 10 mg/kg (max 600 mg) daily.
• Ethambutol (EMB) – 15–25 mg/kg daily (for the first 2 months).
• Streptomycin (SM) or Amikacin – considered in severe disease or when EMB cannot be used.
• Duration: 2 months intensive phase (INH + RIF + EMB ± SM) followed by 4–7 months continuation phase (INH + RIF). Total 6–9 months depending on site of disease and response.

Monitoring & side‑effects

• Baseline liver function tests (LFTs) and visual acuity (for EMB).
• Monthly LFTs during therapy; adjust or discontinue if transaminases >3× ULN with symptoms.
• Peripheral neuropathy risk with INH – give pyridoxine (vitamin B6) 25 mg daily.
• Rifampin may cause orange discoloration of body fluids and interact with oral contraceptives, warfarin, and some antiretrovirals.

Special cases

• HIV‑co‑infection: Start antiretroviral therapy (ART) 2–8 weeks after TB treatment begins, per CDC guidelines.
• Pregnancy: INH, RIF, and EMB are considered safe; avoid streptomycin (ototoxic to the fetus).
• Drug‑resistant isolates: If additional resistance is identified, refer to a specialist TB center for second‑line regimen (fluoroquinolones, bedaquiline, linezolid, etc.).

Living with Zoonotic Tuberculosis (Mycobacterium bovis)

Adhering to treatment and maintaining a supportive lifestyle are critical for cure and for preventing transmission.

Medication adherence

• Take doses at the same time each day; use pill boxes or phone alarms.
• Never skip or stop medication without consulting your provider—even if you feel better.
• Report side‑effects promptly; many can be managed without stopping therapy.

Nutrition & general health

• Consume a balanced diet rich in protein, fruits, and vegetables to support immune recovery.
• Stay hydrated; aim for ≥2 L of water daily unless otherwise instructed.
• Limit alcohol and avoid smoking—both impair lung healing and increase liver toxicity risk.

Infection control at home

• Cover mouth/nose with a tissue or mask when coughing; dispose of tissues immediately.
• Ventilate rooms daily (open windows for ≥30 min).
• Disinfect frequently touched surfaces (doorknobs, bathroom fixtures) with a bleach solution (1 tsp bleach per liter water) weekly.
• Household members should undergo TB screening (IGRA or TST). Prophylactic INH may be recommended for close contacts.

Follow‑up care

• Monthly clinic visits for sputum microscopy/culture until conversion (negative sputum).
• Repeat chest X‑ray at 2 months and at completion of therapy to document healing.
• Post‑treatment evaluation 6 months later to ensure no relapse.

Prevention

Because zoonotic TB originates in animals, a One‑Health approach—coordinated actions across human health, veterinary, and environmental sectors—is essential.

Personal preventive measures

• Consume only pasteurized dairy: Heat treatment kills M. bovis. If you live in an endemic area, avoid unpasteurized milk, cheese, and ice‑cream.
• Cook meat thoroughly: Internal temperature of ≥71 °C (160 °F) for beef, pork, and lamb.
• Use protective equipment: Gloves, face shields, and respirators (N95) when handling sick animals, carcasses, or during necropsy.
• Wound care: Clean any skin cuts immediately with soap and water; apply antiseptic.
• Vaccination of cattle: In many countries, BCG vaccination of calves and test‑and‑cull programs reduce herd infection rates.

Community and public‑health actions

• Regular bovine TB testing of livestock (skin test, interferon‑gamma assay) and culling of positives.
• Wildlife management: vaccination of deer or badgers where wildlife reservoirs exist.
• Public education campaigns about the dangers of raw milk.
• Strengthening laboratory capacity to rapidly differentiate M. bovis from M. tuberculosis.

Complications

If left untreated or inadequately treated, zoonotic TB can lead to severe, sometimes irreversible damage.

• Pulmonary cavitation – destroyed lung tissue, leading to chronic cough, hemoptysis, and increased transmission risk.
• Spread to other organs – meningitis, spinal (Pott) disease, or genitourinary TB, each associated with neurological deficits, paralysis, infertility, or renal failure.
• Drug‑resistant disease – inadequate therapy can select for multidrug‑resistant (MDR) strains, which are harder to cure.
• Secondary infections – especially in immunocompromised patients, TB can coexist with bacterial pneumonia or fungal infections.
• Mortality – WHO estimates a global mortality of ~1.5 million TB deaths per year; zoonotic TB contributes a small but significant proportion, particularly in settings with limited health care access.

When to Seek Emergency Care

References

1. Centers for Disease Control and Prevention. Zoonotic Tuberculosis (Mycobacterium bovis). 2023. https://www.cdc.gov/tb/topic/bovis.htm
2. World Health Organization. Global Tuberculosis Report 2023. https://www.who.int/publications/i/item/9789241565711
3. Mayo Clinic. Tuberculosis (TB). 2024. https://www.mayoclinic.org/diseases-conditions/tuberculosis/symptoms-causes/syc-20351250
4. Cleveland Clinic. Tuberculosis Treatment Guidelines. 2024. https://my.clevelandclinic.org/health/diseases/24162-tuberculosis
5. National Institute of Allergy and Infectious Diseases. Tuberculosis (TB) – Fact Sheet. 2022. https://www.niaid.nih.gov/diseases-conditions/tuberculosis
6. World Organisation for Animal Health (WOAH). Bovine Tuberculosis. 2023. https://www.oie.int/en/animal-health-in-the-world/animal-diseases/bovine-tb/

```